Vyndaqel (Tafamidis Meglumine)

Vyndaqel (Tafamidis Meglumine)

Vyndaqel

Tafamidis Meglumine

Capsules: 20 mg 

Pfizer Inc.

Medical Use

Vyndaqel is a medication that stabilizes transthyretin, used to treat cardiomyopathy caused by wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. It helps reduce cardiovascular mortality and hospitalizations related to heart issues.

Recommended Dosage :

Take 80 mg of Vyndaqel daily, which equals four 20 mg tafamidis meglumine capsules. Swallow the capsules whole without crushing or cutting them. You can take this medication with or without food.

If you vomit after taking Vyndaqel and see the intact capsule, take another dose if possible. If you don’t see the capsule, do not take an additional dose. Continue with your regular dosing schedule the next day.